0.6400
-0.0200
(-3.03%)
At close: January 10 at 9:17:53 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-21,070.2230
-21,070.2230
-21,384.6190
-10,769.8720
-5,314.0970
Investing Cash Flow
-381.0570
-381.0570
-1,543.8690
-686.0280
-164.9270
Financing Cash Flow
32,202.9820
32,202.9820
-841.0900
-715.0670
37,225.6540
End Cash Position
36,974.0090
36,974.0090
26,203.9050
50,001.1100
62,174.9480
Capital Expenditure
-868.7260
-868.7260
-1,514.2280
-652.7290
-164.9270
Issuance of Capital Stock
33,064.4430
33,064.4430
63.8560
45.0040
53,772.6200
Issuance of Debt
21,229.8330
--
--
--
--
Repayment of Debt
--
--
--
--
-20,000.0000
Repurchase of Capital Stock
--
--
--
--
-3.3870
Free Cash Flow
-21,938.9490
-21,938.9490
-22,898.8470
-11,422.6010
-5,479.0240
12/31/2020 - 2/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MEDCL.PA MedinCell S.A.
16.48
-2.25%
BIOA-B.ST BioArctic AB (publ)
206.80
+1.08%
ABVX ABIVAX Société Anonyme
6.38
-4.49%
RADX Radiopharm Theranostics Limited
5.35
+30.17%
LXEO Lexeo Therapeutics, Inc.
6.39
-6.30%
RAPP Rapport Therapeutics, Inc.
14.81
-11.26%
NGNE Neurogene Inc.
19.58
-8.89%
MBX MBX Biosciences, Inc.
13.69
-5.65%
XENE Xenon Pharmaceuticals Inc.
38.41
-2.88%
GHRS GH Research PLC
8.57
-4.57%